What is the life expectancy of a person with interstitial lung disease?
I'll answer
Earn 20 gold coins for an accepted answer.20
Earn 20 gold coins for an accepted answer.
40more
40more
Charlotte Nelson
Studied at the University of Lagos, Lives in Lagos, Nigeria.
As a pulmonologist with extensive experience in respiratory diseases, I can provide you with information on the life expectancy of individuals with interstitial lung disease (ILD). ILD is a complex group of disorders characterized by inflammation and scarring of lung tissue, which can significantly impact a person's quality of life and longevity.
The life expectancy for someone with ILD can vary widely depending on several factors, including the specific type of ILD, the stage at which the disease is diagnosed, the overall health of the individual, and the effectiveness of the treatments available. It's important to note that while some reports may suggest an average life expectancy of three to five years, this is a generalization and individual cases can differ significantly.
Recent advancements in medical research and treatment options have led to new drugs that can significantly slow the progression of this fatal lung disease. These treatments, along with supportive care and lifestyle modifications, can potentially extend life expectancy beyond the averages previously mentioned.
It's crucial for patients with ILD to work closely with their healthcare team to develop a personalized treatment plan that addresses their specific needs and circumstances. Early diagnosis and intervention are also key factors in managing the disease and improving outcomes.
Works at Microsoft, Lives in Redmond, WA
New drug significantly slows progression of fatal lung disease. ... The condition, which is part of a group of disorders known collectively as interstitial lung disease, causes inflammation and scarring of the lung tissue and sufferers have an average life expectancy of between just three and five years.
2014-5-19
评论(0)
Helpful(2)
Helpful
Helpful(2)
Ella Brown
QuesHub.com delivers expert answers and knowledge to you.
New drug significantly slows progression of fatal lung disease. ... The condition, which is part of a group of disorders known collectively as interstitial lung disease, causes inflammation and scarring of the lung tissue and sufferers have an average life expectancy of between just three and five years.